Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL668 (Protriptyline) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
NET/Norepinephrine transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL222] [GtoPdb: 926] [UniProtKB: P23975] | ||||||||
GtoPdb | - | - | 8.85 | pKd | 1.41 | nM | Kd | Eur J Pharmacol (1997) 340: 249-58 [PMID:9537821] |
ChEMBL | Inhibition of human NET | B | 8.85 | pKd | 1.4 | nM | Kd | J Med Chem (2010) 53: 7869-7873 [PMID:20945906] |
ChEMBL | Displacement of radiolabeled protriptyline from human NET | B | 8.17 | pKi | 6.8 | nM | Ki | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
GtoPdb | - | - | 8.17 | pKi | 6.8 | nM | Ki | J Med Chem (2008) 51: 7094-8 [PMID:18983139] |
ChEMBL | Displacement of [3H]nisoxetine from human NE transporter | B | 8.64 | pKi | 2.3 | nM | Ki | J Med Chem (2011) 54: 5320-5334 [PMID:21726069] |
ChEMBL | Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells after 120 mins by scintillation counting | B | 8.68 | pKi | 2.1 | nM | Ki | J Med Chem (2017) 60: 349-361 [PMID:27997171] |
ChEMBL | Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting | B | 8.7 | pKi | 2 | nM | Ki | J Med Chem (2012) 55: 3488-3501 [PMID:22420844] |
ChEMBL | Binding affinity to human norepinephrine transporter by radioligand displacement assay | B | 8.8 | pKi | 1.6 | nM | Ki | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Inhibition of human aorepinephrine transporter | B | 7.77 | pIC50 | 17 | nM | IC50 | Bioorg Med Chem (2010) 18: 7675-7699 [PMID:20875743] |
ChEMBL | Displacement of radiolabeled protriptyline from human NET | B | 8.04 | pIC50 | 9.1 | nM | IC50 | J Med Chem (2008) 51: 7094-7098 [PMID:18983139] |
ChEMBL | Inhibition of human NET | B | 8.15 | pIC50 | 7.1 | nM | IC50 | J Med Chem (2008) 51: 4150-4169 [PMID:18588282] |
ChEMBL | Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells after 120 mins by scintillation counting | B | 8.54 | pIC50 | 2.9 | nM | IC50 | J Med Chem (2017) 60: 349-361 [PMID:27997171] |
ChEMBL | Displacement of [3H]nisoxentine from human recombinant norepinephrine transporter expressed in CHO cells | B | 8.55 | pIC50 | 2.8 | nM | IC50 | Bioorg Med Chem (2016) 24: 1793-1810 [PMID:26988801] |
ChEMBL | Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells measured after 120 mins by scintillation counting method | B | 8.55 | pIC50 | 2.8 | nM | IC50 | Bioorg Med Chem (2017) 25: 471-482 [PMID:27876250] |
ChEMBL | Binding affinity to human nonepinephrine transporter by radioligand displacement assay | B | 8.6 | pIC50 | 2.5 | nM | IC50 | Bioorg Med Chem (2013) 21: 2764-2771 [PMID:23582449] |
ChEMBL | Binding affinity to human norepinephrine transporter by radioligand displacement assay | B | 8.68 | pIC50 | 2.1 | nM | IC50 | Eur J Med Chem (2013) 63: 85-94 [PMID:23466604] |
ChEMBL | Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting | B | 8.77 | pIC50 | 1.7 | nM | IC50 | J Med Chem (2012) 55: 3488-3501 [PMID:22420844] |
GtoPdb | Inhibition of [3H]nisoxetine binding to CHO cells expressing hNET. | - | 8.77 | pIC50 | 1.7 | nM | IC50 | J Med Chem (2012) 55: 3488-501 [PMID:22420844] |
ChEMBL | Percent inhibition against Norepinephrine transporter at 1 uM nonselective | B | 8.96 | pIC50 | 1.1 | nM | IC50 | J Med Chem (2005) 48: 6887-6896 [PMID:16250647] |
SERT in Human [GtoPdb: 928] [UniProtKB: P31645] | ||||||||
GtoPdb | - | - | 7.71 | pKd | 19.6 | nM | Kd | Eur J Pharmacol (1997) 340: 249-58 [PMID:9537821] |
ChEMBL data shown on this page come from version 32:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]